Dual Incretin Agonist 11.73mg — Verification Report
From Ion Peptide · Lot ION2T10-04112026 · Tested April 2026
VialTalk
Dual Incretin Agonist 11.73mg
Ion Peptide
Score
106.5
Grade
A++
Superlative
Lot ION2T10-04112026
Tested April 2026
Report ID
d7fc53aa
Test
Method
Result
Status
PurityFull credit
HPLC
99.8%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentFull credit
Gravimetric vs label claim
11.73 mg labeled · 11.73 mg tested
Full credit
EndotoxinFull credit
USP <85> compendial
Screened
Full credit
Heavy metalsFull credit
USP <232>/<233> compendial
Screened
Full credit
SterilityPartial
PCR / DNA microarray
Screened
Partial
Batch conformityPartial
Two-batch average
Assessed
Partial
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/ion-peptide/coas/d7fc53aa-162a-4dec-b9b0-2214cea32bef